Socioeconomic status and inequities in treatment initiation and survival among patients with cancer, 2011-2022
- PMID: 37707536
- PMCID: PMC10582690
- DOI: 10.1093/jncics/pkad058
Socioeconomic status and inequities in treatment initiation and survival among patients with cancer, 2011-2022
Abstract
Background: Lower neighborhood socioeconomic status (SES) is associated with suboptimal cancer care and reduced survival. Most studies examining cancer inequities across area-level socioeconomic status tend to use less granular or unidimensional measures and pre-date the COVID-19 pandemic. Here, we examined the association of area-level socioeconomic status on real-world treatment initiation and overall survival among adults with 20 common cancers.
Methods: This retrospective cohort study used electronic health record-derived deidentified data (Flatiron Health Research Database, 2011-2022) linked to US Census Bureau data from the American Community Survey (2015-2019). Area-level socioeconomic status quintiles (based on a measure incorporating income, home values, rental costs, poverty, blue-collar employment, unemployment, and education information) were computed from the US population and applied to patients based on their mailing address. Associations were examined using Cox proportional hazards models adjusted for diagnosis year, age, sex, performance status, stage, and cancer type.
Results: This cohort included 291 419 patients (47.7% female; median age = 68 years). Patients from low-SES areas were younger and more likely to be Black (21.9% vs 3.3%) or Latinx (8.4% vs 3.0%) than those in high-SES areas. Living in low-SES areas (vs high) was associated with lower treatment rates (hazard ratio = 0.94 [95% confidence interval = 0.93 to 0.95]) and reduced survival (median real-world overall survival = 21.4 vs 29.5 months, hazard ratio = 1.20 [95% confidence interval = 1.18 to 1.22]). Treatment and survival inequities were observed in 9 and 19 cancer types, respectively. Area-level socioeconomic inequities in treatment and survival remained statistically significant in the COVID-19 era (after March 2020).
Conclusion: To reduce inequities in cancer outcomes, efforts that target marginalized, low-socioeconomic status neighborhoods are necessary.
© The Author(s) 2023. Published by Oxford University Press.
Conflict of interest statement
All authors report current or previous employment with Flatiron Health, Inc, which is an independent member of the Roche Holding AG, and stock ownership in Roche. Dr Calip reports research grants from Pfizer. Dr Miksad and Dr Snider report equity ownership in Flatiron Health, Inc (initiated before acquisition by Roche in 2018).
Figures
Comment in
-
Considering context in area-level socioeconomic status, cancer treatment initiation, and survival.JNCI Cancer Spectr. 2023 Aug 31;7(5):pkad078. doi: 10.1093/jncics/pkad078. JNCI Cancer Spectr. 2023. PMID: 37850333 Free PMC article. No abstract available.
References
-
- Shariff-Marco S, Yang J, John EM, et al.Impact of neighborhood and individual socioeconomic status on survival after breast cancer varies by race/ethnicity: the Neighborhood and Breast Cancer Study. Cancer Epidemiol Biomarkers Prev. 2014;23(5):793-811. doi:10.1158/1055-9965.EPI-13-0924 - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical